These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 19631714

  • 1. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M, Yokoyama H, Kato H, Araki T.
    Mol Cell Endocrinol; 2009 Nov 13; 311(1-2):62-8. PubMed ID: 19631714
    [Abstract] [Full Text] [Related]

  • 2. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG.
    Pharmacol Biochem Behav; 2006 Mar 13; 83(3):349-59. PubMed ID: 16580056
    [Abstract] [Full Text] [Related]

  • 3. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 13; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T, Kadoguchi N, Kamiyama Y, Kato H, Maegawa H, Araki T.
    Neuropharmacology; 2006 Mar 13; 50(3):329-44. PubMed ID: 16303147
    [Abstract] [Full Text] [Related]

  • 5. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 6. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 05; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice.
    Kang JM, Jung JC, Kim H, Lim H, Jang S, Oh S.
    Arch Pharm Res; 2008 Sep 05; 31(9):1098-107. PubMed ID: 18806951
    [Abstract] [Full Text] [Related]

  • 8. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B, Leng A, Mura A, Hengerer B, Feldon J.
    J Neurochem; 2004 May 05; 89(4):822-33. PubMed ID: 15140182
    [Abstract] [Full Text] [Related]

  • 9. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 10. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 11. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H, Kurosaki R, Oki C, Araki T.
    Brain Res; 2004 Dec 24; 1030(1):66-73. PubMed ID: 15567338
    [Abstract] [Full Text] [Related]

  • 12. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW.
    J Neurosci Res; 2006 Feb 01; 83(2):332-47. PubMed ID: 16385585
    [Abstract] [Full Text] [Related]

  • 13. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Schumm S, Sebban C, Cohen-Salmon C, Callebert J, Launay JM, Golmard JL, Boussicault L, Petropoulos I, Hild A, Rousselet E, Prigent A, Friguet B, Mariani J, Hirsch EC.
    J Neurochem; 2012 Sep 01; 122(5):1032-46. PubMed ID: 22708926
    [Abstract] [Full Text] [Related]

  • 14. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M, Yokoyama H, Takagi S, Kato H, Araki T.
    Mol Cell Endocrinol; 2008 Dec 16; 296(1-2):87-93. PubMed ID: 18755240
    [Abstract] [Full Text] [Related]

  • 15. Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP.
    Kou J, Bloomquist JR.
    Toxicol Lett; 2007 Jul 10; 171(3):154-61. PubMed ID: 17597311
    [Abstract] [Full Text] [Related]

  • 16. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR.
    Eur J Neurosci; 2009 Mar 10; 29(5):954-63. PubMed ID: 19245367
    [Abstract] [Full Text] [Related]

  • 17. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 10; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 18. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S, Morissette M, Morin N, Di Paolo T.
    J Neuroendocrinol; 2005 Aug 10; 17(8):509-17. PubMed ID: 16011487
    [Abstract] [Full Text] [Related]

  • 19. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease.
    Kurosaki R, Muramatsu Y, Kato H, Araki T.
    Pharmacol Biochem Behav; 2004 May 10; 78(1):143-53. PubMed ID: 15159144
    [Abstract] [Full Text] [Related]

  • 20. MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.
    Ali SF, David SN, Newport GD, Cadet JL, Slikker W.
    Synapse; 1994 Sep 10; 18(1):27-34. PubMed ID: 7825121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.